UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Elevated expression of caveolin is associated with prostate and breast cancer

Clinical cancer research, 1998-08, Vol.4 (8), p.1873-1880

1998

Volltextzugriff (PDF)

Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.3882-3885

2001

Volltextzugriff (PDF)

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer : suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

Gene therapy, 1999-03, Vol.6 (3), p.338-349

1999

Volltextzugriff (PDF)

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (11), p.4386-4392

2001

Volltextzugriff (PDF)

In situ gene therapy for adenocarcinoma of the prostate : A phase I clinical trial

Human gene therapy, 1999-05, Vol.10 (7), p.1239-1249

1999

Volltextzugriff (PDF)

Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis

Oncogene, 2000-07, Vol.19 (29), p.3256-3265

2000

Volltextzugriff (PDF)

In vivo gene therapy with p53 or p21 adenovirus for prostate cancer

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (22), p.5151-5155

1995

Volltextzugriff (PDF)

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer

Gene therapy, 2007-02, Vol.14 (3), p.227-236

2007

Volltextzugriff (PDF)

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

Human gene therapy, 2001-11, Vol.12 (16), p.1955-1967

2001

Volltextzugriff (PDF)

Reduced lysyl oxidase messenger rna levels in experimental and human prostate cancer

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (6), p.1285-1290

1998

Volltextzugriff (PDF)

Association of p53 mutations with metastatic prostate cancer

Clinical cancer research, 1995-10, Vol.1 (10), p.1111-1118

1995

Volltextzugriff (PDF)

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases

Clinical cancer research, 1997-08, Vol.3 (8), p.1389-1397

1997

Volltextzugriff (PDF)

Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study

Clinical cancer research, 1996-04, Vol.2 (4), p.635-640

1996

Volltextzugriff (PDF)

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model

Cancer gene therapy, 2006-01, Vol.13 (1), p.91-98

2006

Volltextzugriff (PDF)

Prostate Cancer Gene Therapy: Comparison of Adenovirus-mediated Expression of Interleukin 12 with Interleukin 12 plus B7-1 for in Situ Gene Therapy and Gene-modified, Cell-based Vaccines

Clinical cancer research, 2000-10, Vol.6 (10), p.4101-4109

2000

Volltextzugriff (PDF)

Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer

Apoptosis (London), 1999-08, Vol.4 (4), p.233-237

1999

Volltextzugriff (PDF)

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer

Oncogene, 1995-03, Vol.10 (5), p.869-879

1995

Volltextzugriff (PDF)

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters

Prostate cancer and prostatic diseases, 2002-12, Vol.5 (4), p.316-325

2002

Volltextzugriff (PDF)

Rapid allelotype analysis of p53 knockout mice

BioTechniques, 1994-09, Vol.17 (3), p.460, 462

1994

Volltextzugriff (PDF)

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression

Clinical cancer research, 1996-02, Vol.2 (2), p.399-401

1996

Volltextzugriff (PDF)

Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7853-7860

2003

Volltextzugriff (PDF)

RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (3), p.969-976

2004

Volltextzugriff (PDF)

Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

Nature medicine, 1998-09, Vol.4 (9), p.1062-1064

1998

Volltextzugriff (PDF)

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer

Prostate cancer and prostatic diseases, 2001, Vol.4 (1), p.44-55

2001

Volltextzugriff (PDF)

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

International journal of radiation oncology, biology, physics, 2004-04, Vol.58 (5), p.1520-1529

2004

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(203)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(215)
Japanisch
(33)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(123)
Humans
(79)
Male
(74)
Animals
(61)
Biological And Medical Sciences
(58)
Mice
(48)
Oncology
(44)
Medical Sciences
(39)
Prostate Cancer
(32)
Prostatic Neoplasms - Pathology
(29)
Gene Therapy
(25)
Female
(23)
Prostatic Neoplasms - Therapy
(23)
Genetics & Heredity
(22)
Physical Sciences
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Nephrology. Urinary Tract Diseases
(20)
Prostatic Neoplasms - Genetics
(19)
Biotechnology & Applied Microbiology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Elevated expression of caveolin is associated with prostate and breast cancer

Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer : suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells

In situ gene therapy for adenocarcinoma of the prostate : A phase I clinical trial

Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis

In vivo gene therapy with p53 or p21 adenovirus for prostate cancer

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

Reduced lysyl oxidase messenger rna levels in experimental and human prostate cancer

Association of p53 mutations with metastatic prostate cancer

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases

Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model

Prostate Cancer Gene Therapy: Comparison of Adenovirus-mediated Expression of Interleukin 12 with Interleukin 12 plus B7-1 for in Situ Gene Therapy and Gene-modified, Cell-based Vaccines

Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters

Rapid allelotype analysis of p53 knockout mice

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression

Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model

RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer

Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

Suchergebnisse filtern